SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?


To: arun gera who wrote (176364)8/14/2021 10:57:01 PM
From: TobagoJack  Read Replies (2) | Respond to of 217671
 
As mentioned, in HK we get both CoronaVac and BioNTech

At least one person deliberately got both (Moderna in Singapore and BioNTech in HK) so as to visit HK bars sooner (Moderna not (yet) recognized as valid here, just like Boeing 737Max)
drugoffice.gov.hk




To: arun gera who wrote (176364)8/15/2021 2:32:55 AM
From: TobagoJack2 Recommendations

Recommended By
maceng2
marcher

  Respond to of 217671
 
I continue to track this thread and watch to see what if anything happens that either says, ‘of merit’ or ‘garbage’

The vaccine is a politicized issue in Brazil, am told, so let’s see if science can thrive in arena polluted by politics

And, no, << CoronaVac had efficacy rates as low as 50%>> at the get go was misreported by usual suspects. Was ‘at least 50% effective’ at first report time but twisted, no doubt inadvertent, as ‘as low as’ and that language took hold, much as the dumb idea about China spy chip in Amazon and Apple devices.

I am being charitable. The truth of such cheap trickery tells us much.

economist.com

A town in Brazil has vaccinated nearly everyone against covid-19
Its success shows what could have been in the rest of the country

Jun 12th 2021

BEFORE THE pandemic, Celso Vigo walked for 90 minutes each day through the streets of Serrana, a town of 45,000 people surrounded by sugarcane fields in the state of São Paulo. But when covid-19 hit, the 75-year-old retired bank clerk, who played football “well into my 60s”, was reduced to doing loops around his house. It reminded him of how Brazil, too, was going in circles. After a second wave killed 87,000 people in April, cases and deaths remain high.

Listen to this storyEnjoy more audio and podcasts on iOSor Android.

But Serrana was given a way out. Between February and April, all adults were offered jabs as part of a study by the Butantan Institute, which produces CoronaVac, a vaccine developed by Sinovac, a Chinese firm. More than 95% of serranenses got jabbed, despite Jair Bolsonaro, the president, claiming that it was unsafe. Preliminary results released on May 31st showed that symptomatic cases and deaths fell by 80% and 95%, respectively. Only two covid-19 patients remain hospitalised in the local clinic (both refused the vaccine). Mr Vigo is once again pounding the pavements.

Serrana is a tantalising glimpse of an alternative reality in Brazil—one in which Mr Bolsonaro did not squander his chances to mount an effective public-health campaign and, later, to buy vaccines. But the study also has global implications. In phase three trials, CoronaVac had efficacy rates as low as 50%, the minimum required by the WHO. The lower the efficacy, the higher the share of people who must be jabbed to slow contagion. The trial in Serrana sought to discover that share. The town was split into four cohorts, that got jabbed in successive weeks. Contagion dropped dramatically after three out of the four had received two doses of the vaccine, suggesting that herd immunity is attained at around 75%.

These results could boost vaccine uptake across Brazil, hopes Ethel Maciel, an epidemiologist. But 75% is a long way off. Only 11% of Brazilians are fully vaccinated, and the rate has slowed because of a shortage of ingredients for CoronaVac, which are imported from China. Chile, which has vaccinated 45% of its population, mostly with CoronaVac, is also suffering near-record cases.

But Serrana itself has become an oasis. On a recent morning, children ran round a fountain in the plaza. Across the street a fabric shop that caters to elderly women had a steady stream of customers. A gang of old men occupied their usual benches. They discussed Mr Bolsonaro’s decision to host the Copa América, a football tournament, even though a third wave seems imminent. “Stupid,” a 97-year-old said. Half of them scattered when an outsider showed up. “We’re still scared,” explained Florivaldo Leandro, a retired police officer. Serrana’s calm came at a cost, he said. “We lost friends, neighbours and relatives. Our conscientiousness was forced upon us.”

Dig deeper

All our stories relating to the pandemic and the vaccines can be found on our coronavirus hub. You can also listen to The Jab, our podcast on the race between injections and infections, and find trackers showing the global roll-out of vaccines, excess deaths by country and the virus’s spread across Europe and America.

This article appeared in the The Americas section of the print edition under the headline "Now for some good news"

Sent from my iPhone



To: arun gera who wrote (176364)8/15/2021 2:44:54 AM
From: TobagoJack  Respond to of 217671
 
No updates so far except this google.com.hk




To: arun gera who wrote (176364)8/15/2021 2:49:53 AM
From: TobagoJack  Respond to of 217671
 
We watch also a second human trial on city scale

Using AZ stuff

brazilian.report

City sees cases plummet after mass vaccination trial
Lucas BertiJun 28, 2021 14:19
Photo: GovSPLast month, the São Paulo city of Botucatu was the stage of a mass vaccination studyto assess the effects of widespread immunization using the AstraZeneca vaccine. Now, six weeks after the trial began, researchers and local health officials have seen a 71-percent drop in new coronavirus cases.

In the last two weeks alone, Botucatu has seen 45 percent fewer Covid-19 cases, highlighting the efficacy of universal inoculation. A similar experiment using the CoronaVac vaccine was carried out in Serrana, also in São Paulo state. Covid-19 deaths in the 45,000-people city fell 95 percent thanks to the widespread coverage of vaccination.

#pandemic #vaccine

Sent from my iPhone



To: arun gera who wrote (176364)8/15/2021 5:06:33 AM
From: TobagoJack  Read Replies (2) | Respond to of 217671
 
Possibly good news on the vaxx front, in any case could be in the right direction …

I wonder what Sinovac knows that the CIA, to make itself useful, should find out - what is the point of anti-delta shot if the current crop of vaccines used in infested domains are working?

bloomberg.com

Sinovac to Seek Approval to Test Anti-Delta Shot (11:29 a.m. HK)

Beijing-based Sinovac, manufacturer of an inactivated Covid-19 vaccine, will seek approval to do further testing on a shot specifically targeting the delta variant of the coronavirus before October this year, state-backed Global Times reported Sunday, citing the company’s general manager Gao Qiang in a recent interview.

Two shots of Sinovac’s current vaccine that has been widely used in China and across much of the developing world can “remarkably” reduce the risks of developing symptoms and critical illness from infection by the delta variant, Gao was cited as saying by the Global Times.

Gao added that the results of real-world research on using the Sinovac vaccine as a booster shot, following full immunization, conducted in China, Turkey, Chile and other countries, will be obtained soon.